| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sphingolipids | 17 | 2022 | 337 | 4.960 |
Why?
|
| Lipoproteins, LDL | 13 | 2022 | 343 | 2.380 |
Why?
|
| Lupus Erythematosus, Systemic | 5 | 2021 | 756 | 1.970 |
Why?
|
| Macrophages | 7 | 2017 | 647 | 1.710 |
Why?
|
| Diabetes Mellitus, Type 1 | 15 | 2022 | 529 | 1.700 |
Why?
|
| Lipoproteins | 8 | 2022 | 161 | 1.640 |
Why?
|
| Ceramides | 8 | 2020 | 578 | 1.470 |
Why?
|
| Antigen-Antibody Complex | 5 | 2017 | 175 | 1.340 |
Why?
|
| Pre-Eclampsia | 11 | 2020 | 202 | 1.220 |
Why?
|
| Pregnancy in Diabetics | 8 | 2020 | 70 | 0.930 |
Why?
|
| Atherosclerosis | 4 | 2017 | 204 | 0.850 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 5 | 2019 | 201 | 0.820 |
Why?
|
| Biomarkers | 7 | 2021 | 1593 | 0.780 |
Why?
|
| Sphingomyelin Phosphodiesterase | 3 | 2012 | 183 | 0.780 |
Why?
|
| Plaque, Atherosclerotic | 3 | 2021 | 125 | 0.770 |
Why?
|
| Diabetic Neuropathies | 2 | 2021 | 33 | 0.740 |
Why?
|
| Sphingosine | 8 | 2019 | 315 | 0.740 |
Why?
|
| Carotid Artery Diseases | 1 | 2021 | 83 | 0.740 |
Why?
|
| Lysophospholipids | 7 | 2019 | 209 | 0.690 |
Why?
|
| Tandem Mass Spectrometry | 3 | 2022 | 139 | 0.670 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2020 | 118 | 0.660 |
Why?
|
| Podocytes | 1 | 2020 | 113 | 0.630 |
Why?
|
| Transcriptome | 1 | 2020 | 164 | 0.630 |
Why?
|
| Lipoproteins, HDL | 5 | 2016 | 113 | 0.600 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2022 | 1085 | 0.580 |
Why?
|
| Health Status Disparities | 1 | 2019 | 326 | 0.540 |
Why?
|
| Diabetic Nephropathies | 4 | 2022 | 161 | 0.510 |
Why?
|
| Sphingomyelins | 4 | 2018 | 106 | 0.510 |
Why?
|
| Signal Transduction | 6 | 2020 | 2689 | 0.500 |
Why?
|
| Coturnix | 5 | 1998 | 22 | 0.500 |
Why?
|
| Humans | 51 | 2022 | 68618 | 0.500 |
Why?
|
| Cholesterol, Dietary | 5 | 1998 | 22 | 0.500 |
Why?
|
| Homeostasis | 2 | 2019 | 291 | 0.480 |
Why?
|
| Cholesterol | 7 | 2012 | 331 | 0.450 |
Why?
|
| Animals | 28 | 2020 | 20881 | 0.450 |
Why?
|
| Oxidative Stress | 5 | 2019 | 718 | 0.440 |
Why?
|
| Cardiovascular Diseases | 2 | 2019 | 940 | 0.430 |
Why?
|
| Cytokines | 3 | 2017 | 866 | 0.420 |
Why?
|
| Macrophage Activation | 2 | 2010 | 75 | 0.410 |
Why?
|
| Chromatography, High Pressure Liquid | 3 | 2019 | 381 | 0.410 |
Why?
|
| Phagocytosis | 1 | 2012 | 65 | 0.410 |
Why?
|
| Aorta | 3 | 2016 | 316 | 0.400 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2012 | 201 | 0.390 |
Why?
|
| Cholesterol, HDL | 4 | 2020 | 112 | 0.390 |
Why?
|
| Apoptosis | 7 | 2020 | 1641 | 0.390 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2012 | 102 | 0.380 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2003 | 195 | 0.370 |
Why?
|
| Endocytosis | 3 | 2000 | 113 | 0.370 |
Why?
|
| Mice | 14 | 2018 | 8474 | 0.350 |
Why?
|
| Receptors, LDL | 5 | 2008 | 72 | 0.350 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2010 | 42 | 0.350 |
Why?
|
| Pregnancy Trimester, First | 3 | 2020 | 43 | 0.350 |
Why?
|
| Foam Cells | 2 | 2008 | 26 | 0.350 |
Why?
|
| Receptors, Cell Surface | 3 | 2008 | 248 | 0.340 |
Why?
|
| Receptors, Lysosphingolipid | 4 | 2016 | 63 | 0.330 |
Why?
|
| Kidney | 4 | 2022 | 945 | 0.330 |
Why?
|
| Membrane Glycoproteins | 3 | 2000 | 370 | 0.310 |
Why?
|
| Pericytes | 3 | 2016 | 81 | 0.300 |
Why?
|
| Inflammation | 3 | 2011 | 1030 | 0.290 |
Why?
|
| Prognosis | 3 | 2021 | 2093 | 0.290 |
Why?
|
| Monocytes | 1 | 2008 | 210 | 0.290 |
Why?
|
| Disease Progression | 4 | 2019 | 1038 | 0.270 |
Why?
|
| Adult | 15 | 2021 | 21403 | 0.270 |
Why?
|
| Cross-Sectional Studies | 5 | 2021 | 2279 | 0.270 |
Why?
|
| Cell Line | 4 | 2020 | 1752 | 0.270 |
Why?
|
| Pregnancy | 12 | 2020 | 2334 | 0.260 |
Why?
|
| Female | 22 | 2021 | 38074 | 0.250 |
Why?
|
| Hypercholesterolemia | 2 | 2019 | 86 | 0.250 |
Why?
|
| Arteriosclerosis | 4 | 2003 | 137 | 0.240 |
Why?
|
| Cell Survival | 5 | 2016 | 901 | 0.240 |
Why?
|
| Carrier Proteins | 2 | 2015 | 597 | 0.240 |
Why?
|
| U937 Cells | 3 | 2010 | 61 | 0.230 |
Why?
|
| Young Adult | 7 | 2020 | 5717 | 0.230 |
Why?
|
| Diabetic Retinopathy | 2 | 2016 | 110 | 0.230 |
Why?
|
| Albuminuria | 3 | 2017 | 171 | 0.220 |
Why?
|
| Prospective Studies | 7 | 2021 | 3705 | 0.220 |
Why?
|
| Hyperlipidemias | 1 | 2003 | 90 | 0.220 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2022 | 161 | 0.210 |
Why?
|
| Lipid Metabolism | 2 | 2020 | 186 | 0.210 |
Why?
|
| Gene Expression Regulation | 1 | 2008 | 1293 | 0.210 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2003 | 346 | 0.200 |
Why?
|
| Lactosylceramides | 1 | 2022 | 27 | 0.200 |
Why?
|
| Asymptomatic Diseases | 1 | 2021 | 43 | 0.190 |
Why?
|
| Protein Transport | 3 | 2012 | 280 | 0.190 |
Why?
|
| Lysosomes | 2 | 2012 | 136 | 0.180 |
Why?
|
| Up-Regulation | 3 | 2019 | 682 | 0.180 |
Why?
|
| Retinal Vessels | 2 | 2012 | 74 | 0.180 |
Why?
|
| Disease Models, Animal | 4 | 2019 | 2550 | 0.180 |
Why?
|
| Vitamin D-Binding Protein | 1 | 2020 | 58 | 0.180 |
Why?
|
| Carbon Isotopes | 1 | 2020 | 54 | 0.180 |
Why?
|
| Focal Adhesions | 1 | 2020 | 25 | 0.180 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 1465 | 0.180 |
Why?
|
| Receptors, Lipoprotein | 1 | 1999 | 11 | 0.170 |
Why?
|
| Male | 13 | 2021 | 37321 | 0.170 |
Why?
|
| Haptoglobins | 1 | 2019 | 12 | 0.170 |
Why?
|
| Endoderm | 1 | 1999 | 37 | 0.170 |
Why?
|
| Kidney Tubules, Proximal | 1 | 1999 | 81 | 0.170 |
Why?
|
| Cell Membrane | 2 | 2019 | 525 | 0.170 |
Why?
|
| Ultrasonography | 1 | 2021 | 453 | 0.170 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2019 | 31 | 0.160 |
Why?
|
| ATP Binding Cassette Transporter 1 | 1 | 2018 | 13 | 0.160 |
Why?
|
| Mass Spectrometry | 1 | 2019 | 284 | 0.160 |
Why?
|
| Phosphorylation | 2 | 2020 | 1200 | 0.160 |
Why?
|
| Fatty Liver | 1 | 2019 | 97 | 0.160 |
Why?
|
| Mice, Knockout | 3 | 2012 | 1692 | 0.160 |
Why?
|
| Mutation, Missense | 1 | 2019 | 112 | 0.150 |
Why?
|
| Case-Control Studies | 2 | 2019 | 1553 | 0.150 |
Why?
|
| Glycation End Products, Advanced | 3 | 2016 | 125 | 0.150 |
Why?
|
| Vitamin D | 2 | 2020 | 516 | 0.150 |
Why?
|
| Adipokines | 1 | 2017 | 20 | 0.150 |
Why?
|
| RNA-Binding Proteins | 1 | 1999 | 215 | 0.150 |
Why?
|
| Cell Cycle | 1 | 2019 | 312 | 0.150 |
Why?
|
| Triglycerides | 1 | 1998 | 184 | 0.150 |
Why?
|
| Malondialdehyde | 1 | 2017 | 43 | 0.150 |
Why?
|
| Health | 1 | 2017 | 26 | 0.150 |
Why?
|
| Cell Line, Tumor | 3 | 2018 | 1851 | 0.150 |
Why?
|
| MAP Kinase Signaling System | 4 | 2016 | 247 | 0.140 |
Why?
|
| Scavenger Receptors, Class B | 1 | 2016 | 18 | 0.140 |
Why?
|
| Molecular Chaperones | 1 | 1997 | 81 | 0.140 |
Why?
|
| Autophagy | 2 | 2016 | 208 | 0.140 |
Why?
|
| Metabolic Diseases | 1 | 2017 | 37 | 0.140 |
Why?
|
| Egg Yolk | 1 | 1996 | 13 | 0.140 |
Why?
|
| Sensation Disorders | 1 | 2016 | 14 | 0.140 |
Why?
|
| Observational Studies as Topic | 1 | 2016 | 39 | 0.140 |
Why?
|
| Glycosphingolipids | 1 | 2016 | 51 | 0.130 |
Why?
|
| Cysteine | 1 | 2016 | 112 | 0.130 |
Why?
|
| Glycoproteins | 1 | 1997 | 238 | 0.130 |
Why?
|
| Amino Acids | 1 | 2016 | 131 | 0.130 |
Why?
|
| Amyloid beta-Peptides | 1 | 1997 | 191 | 0.130 |
Why?
|
| Comorbidity | 1 | 2019 | 1426 | 0.130 |
Why?
|
| Integrin beta1 | 1 | 2015 | 48 | 0.120 |
Why?
|
| Kidney Diseases | 1 | 2017 | 307 | 0.120 |
Why?
|
| Zinc | 1 | 2015 | 73 | 0.120 |
Why?
|
| Autoantibodies | 1 | 2017 | 434 | 0.120 |
Why?
|
| Calcium-Binding Proteins | 1 | 2015 | 114 | 0.120 |
Why?
|
| Alternative Splicing | 1 | 2015 | 93 | 0.120 |
Why?
|
| Time Factors | 2 | 2021 | 4655 | 0.120 |
Why?
|
| RNA, Small Interfering | 3 | 2012 | 434 | 0.120 |
Why?
|
| Staff Development | 1 | 2014 | 35 | 0.120 |
Why?
|
| Health Occupations | 1 | 2014 | 28 | 0.120 |
Why?
|
| Placenta | 1 | 2015 | 101 | 0.120 |
Why?
|
| Middle Aged | 3 | 2021 | 21147 | 0.120 |
Why?
|
| Odds Ratio | 1 | 2016 | 880 | 0.120 |
Why?
|
| Faculty | 1 | 2014 | 56 | 0.120 |
Why?
|
| Copper | 1 | 2015 | 149 | 0.110 |
Why?
|
| APOBEC-1 Deaminase | 2 | 2003 | 6 | 0.110 |
Why?
|
| Cytidine Deaminase | 2 | 2003 | 17 | 0.110 |
Why?
|
| Interprofessional Relations | 1 | 2014 | 188 | 0.110 |
Why?
|
| Academic Medical Centers | 1 | 2014 | 281 | 0.100 |
Why?
|
| Receptors, Immunologic | 1 | 2012 | 72 | 0.100 |
Why?
|
| Pilot Projects | 1 | 2016 | 1342 | 0.100 |
Why?
|
| Longitudinal Studies | 4 | 2020 | 1054 | 0.100 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2012 | 76 | 0.100 |
Why?
|
| Mesangial Cells | 1 | 2012 | 37 | 0.100 |
Why?
|
| Exosomes | 1 | 2012 | 44 | 0.100 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2012 | 507 | 0.100 |
Why?
|
| Endoplasmic Reticulum Stress | 3 | 2019 | 99 | 0.100 |
Why?
|
| Receptors, IgG | 2 | 2017 | 94 | 0.100 |
Why?
|
| Carotenoids | 1 | 2011 | 45 | 0.100 |
Why?
|
| Lipid Metabolism, Inborn Errors | 1 | 2011 | 6 | 0.100 |
Why?
|
| Transcriptional Activation | 1 | 2012 | 226 | 0.090 |
Why?
|
| Blood Cells | 1 | 2011 | 27 | 0.090 |
Why?
|
| Gene Expression | 2 | 2017 | 770 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2017 | 626 | 0.090 |
Why?
|
| Lipoproteins, HDL2 | 1 | 2010 | 4 | 0.090 |
Why?
|
| Lipoproteins, HDL3 | 1 | 2010 | 4 | 0.090 |
Why?
|
| Endosomes | 1 | 2010 | 45 | 0.090 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2010 | 58 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2008 | 320 | 0.090 |
Why?
|
| Adipocytes | 1 | 2010 | 88 | 0.090 |
Why?
|
| Follow-Up Studies | 1 | 2016 | 3259 | 0.090 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 2 | 2021 | 59 | 0.090 |
Why?
|
| Matrix Metalloproteinase 1 | 2 | 2021 | 74 | 0.080 |
Why?
|
| Heparin | 1 | 2010 | 205 | 0.080 |
Why?
|
| RNA, Messenger | 2 | 2012 | 1664 | 0.080 |
Why?
|
| Interleukin-10 | 1 | 2010 | 144 | 0.080 |
Why?
|
| Heymann Nephritis Antigenic Complex | 2 | 2000 | 3 | 0.080 |
Why?
|
| Antibodies | 1 | 2010 | 241 | 0.080 |
Why?
|
| Microscopy, Confocal | 2 | 2000 | 337 | 0.080 |
Why?
|
| Gene Expression Profiling | 2 | 2008 | 498 | 0.080 |
Why?
|
| Coronary Disease | 1 | 2011 | 358 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 3 | 2018 | 2791 | 0.080 |
Why?
|
| Hemocyanins | 1 | 2008 | 14 | 0.080 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2008 | 64 | 0.080 |
Why?
|
| Proteomics | 1 | 2010 | 246 | 0.080 |
Why?
|
| Marine Toxins | 1 | 2008 | 14 | 0.080 |
Why?
|
| Spiro Compounds | 1 | 2008 | 14 | 0.080 |
Why?
|
| Norway | 2 | 2019 | 18 | 0.080 |
Why?
|
| Swine | 2 | 2000 | 672 | 0.070 |
Why?
|
| Kinetics | 2 | 1999 | 1047 | 0.070 |
Why?
|
| Cells, Cultured | 4 | 2015 | 2673 | 0.070 |
Why?
|
| Australia | 2 | 2019 | 235 | 0.070 |
Why?
|
| Cholesterol Esters | 2 | 1996 | 26 | 0.070 |
Why?
|
| Glycosylation | 2 | 2019 | 185 | 0.060 |
Why?
|
| Lipopolysaccharides | 1 | 2007 | 455 | 0.060 |
Why?
|
| Cell Movement | 1 | 2008 | 630 | 0.060 |
Why?
|
| Endothelial Cells | 1 | 2008 | 384 | 0.060 |
Why?
|
| Dyslipidemias | 2 | 2019 | 98 | 0.060 |
Why?
|
| Rats | 3 | 2016 | 5300 | 0.060 |
Why?
|
| T-Lymphocytes | 1 | 2008 | 597 | 0.060 |
Why?
|
| Basement Membrane | 1 | 2003 | 48 | 0.050 |
Why?
|
| Streptozocin | 1 | 2003 | 34 | 0.050 |
Why?
|
| Particle Size | 1 | 2003 | 201 | 0.050 |
Why?
|
| Protein Isoforms | 2 | 2015 | 246 | 0.050 |
Why?
|
| Apolipoproteins M | 1 | 2022 | 5 | 0.050 |
Why?
|
| Microscopy, Electron | 1 | 2003 | 351 | 0.050 |
Why?
|
| Retina | 2 | 2016 | 252 | 0.050 |
Why?
|
| Species Specificity | 3 | 1998 | 303 | 0.050 |
Why?
|
| Kidney Tubules | 1 | 2003 | 80 | 0.050 |
Why?
|
| Schwann Cells | 1 | 2021 | 33 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2019 | 2358 | 0.050 |
Why?
|
| Lipids | 1 | 2003 | 298 | 0.050 |
Why?
|
| Mitochondria | 2 | 2019 | 643 | 0.050 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2021 | 145 | 0.050 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2020 | 58 | 0.050 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2000 | 48 | 0.040 |
Why?
|
| Matrix Metalloproteinases | 1 | 2021 | 223 | 0.040 |
Why?
|
| Imidazoles | 2 | 2012 | 175 | 0.040 |
Why?
|
| Apolipoprotein A-II | 1 | 1999 | 3 | 0.040 |
Why?
|
| Yolk Sac | 1 | 1999 | 10 | 0.040 |
Why?
|
| Apolipoprotein C-III | 1 | 1999 | 12 | 0.040 |
Why?
|
| Apolipoproteins C | 1 | 1999 | 15 | 0.040 |
Why?
|
| Tretinoin | 1 | 2000 | 92 | 0.040 |
Why?
|
| Apolipoprotein A-I | 1 | 1999 | 29 | 0.040 |
Why?
|
| Collagen | 1 | 2003 | 636 | 0.040 |
Why?
|
| Chromatography, Affinity | 1 | 1999 | 73 | 0.040 |
Why?
|
| Rabbits | 1 | 2000 | 509 | 0.040 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2019 | 59 | 0.040 |
Why?
|
| Risk Factors | 2 | 2019 | 5731 | 0.040 |
Why?
|
| Pregnancy Outcome | 1 | 2019 | 157 | 0.040 |
Why?
|
| Apolipoproteins | 1 | 2018 | 51 | 0.040 |
Why?
|
| Zebrafish Proteins | 1 | 2019 | 100 | 0.040 |
Why?
|
| Diet, Atherogenic | 1 | 1998 | 6 | 0.040 |
Why?
|
| Cholesterol, VLDL | 1 | 1998 | 17 | 0.040 |
Why?
|
| Brachiocephalic Trunk | 1 | 1998 | 11 | 0.040 |
Why?
|
| Hepatitis A Virus Cellular Receptor 1 | 1 | 2017 | 9 | 0.040 |
Why?
|
| Zebrafish | 1 | 2019 | 187 | 0.040 |
Why?
|
| Lipocalin-2 | 1 | 2017 | 19 | 0.040 |
Why?
|
| Retinol-Binding Proteins, Plasma | 1 | 2017 | 12 | 0.040 |
Why?
|
| Resistin | 1 | 2017 | 9 | 0.040 |
Why?
|
| Clusterin | 1 | 1997 | 13 | 0.040 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2017 | 30 | 0.040 |
Why?
|
| Ovalbumin | 1 | 1997 | 33 | 0.040 |
Why?
|
| Vitamin D Deficiency | 1 | 2020 | 292 | 0.040 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2017 | 27 | 0.040 |
Why?
|
| Adiponectin | 1 | 2017 | 52 | 0.040 |
Why?
|
| Cholesterol, LDL | 1 | 1998 | 161 | 0.040 |
Why?
|
| Leptin | 1 | 2017 | 80 | 0.040 |
Why?
|
| Creatinine | 1 | 2017 | 243 | 0.040 |
Why?
|
| Tritium | 1 | 1997 | 101 | 0.040 |
Why?
|
| Chemokine CCL2 | 1 | 2017 | 101 | 0.040 |
Why?
|
| Glomerular Filtration Rate | 1 | 2017 | 274 | 0.030 |
Why?
|
| Beclin-1 | 1 | 2016 | 11 | 0.030 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2016 | 24 | 0.030 |
Why?
|
| Caspase 3 | 1 | 2017 | 233 | 0.030 |
Why?
|
| Oviposition | 1 | 1996 | 30 | 0.030 |
Why?
|
| Transcription Factor CHOP | 1 | 2016 | 28 | 0.030 |
Why?
|
| Adenine | 1 | 2016 | 46 | 0.030 |
Why?
|
| Organ Culture Techniques | 1 | 2016 | 122 | 0.030 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2017 | 160 | 0.030 |
Why?
|
| Phenotype | 1 | 2019 | 947 | 0.030 |
Why?
|
| Biological Transport | 1 | 2016 | 210 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2018 | 954 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 1997 | 765 | 0.030 |
Why?
|
| Bird Diseases | 1 | 1995 | 1 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2017 | 330 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2016 | 326 | 0.030 |
Why?
|
| Selection, Genetic | 1 | 1995 | 49 | 0.030 |
Why?
|
| Insulin Resistance | 1 | 2017 | 241 | 0.030 |
Why?
|
| Dietary Fats | 1 | 1995 | 103 | 0.030 |
Why?
|
| Integrin alpha5beta1 | 1 | 2015 | 9 | 0.030 |
Why?
|
| United States | 2 | 2019 | 7367 | 0.030 |
Why?
|
| Cricetulus | 1 | 2015 | 98 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2016 | 567 | 0.030 |
Why?
|
| Prenatal Diagnosis | 1 | 2015 | 73 | 0.030 |
Why?
|
| CHO Cells | 1 | 2015 | 161 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2015 | 122 | 0.030 |
Why?
|
| Protein Binding | 1 | 1997 | 1027 | 0.030 |
Why?
|
| Body Weight | 1 | 1996 | 554 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2017 | 867 | 0.030 |
Why?
|
| Risk | 1 | 2015 | 563 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 1174 | 0.030 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2013 | 17 | 0.030 |
Why?
|
| Chemokine CXCL10 | 1 | 2013 | 21 | 0.030 |
Why?
|
| Diabetes Mellitus | 1 | 2019 | 694 | 0.030 |
Why?
|
| Research | 1 | 2014 | 214 | 0.030 |
Why?
|
| Program Development | 1 | 2014 | 240 | 0.030 |
Why?
|
| Liver | 1 | 2018 | 1118 | 0.030 |
Why?
|
| E-Selectin | 1 | 2013 | 44 | 0.030 |
Why?
|
| Poly I | 1 | 2012 | 1 | 0.030 |
Why?
|
| Butylamines | 1 | 2012 | 2 | 0.030 |
Why?
|
| Activating Transcription Factor 6 | 1 | 2012 | 6 | 0.030 |
Why?
|
| Apolipoproteins B | 1 | 2012 | 29 | 0.030 |
Why?
|
| Calcium | 1 | 2016 | 929 | 0.030 |
Why?
|
| Diabetes Complications | 1 | 2014 | 249 | 0.030 |
Why?
|
| Receptor for Advanced Glycation End Products | 1 | 2012 | 19 | 0.030 |
Why?
|
| Lipid Peroxidation | 1 | 2012 | 94 | 0.030 |
Why?
|
| Heat-Shock Proteins | 1 | 2012 | 69 | 0.030 |
Why?
|
| Lysine | 1 | 2012 | 96 | 0.030 |
Why?
|
| C-Reactive Protein | 1 | 2013 | 180 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2012 | 282 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2018 | 1451 | 0.030 |
Why?
|
| Cyclosporine | 1 | 2012 | 121 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2012 | 137 | 0.020 |
Why?
|
| beta Carotene | 1 | 2011 | 16 | 0.020 |
Why?
|
| Linear Models | 1 | 2012 | 521 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2012 | 376 | 0.020 |
Why?
|
| 3T3-L1 Cells | 1 | 2010 | 30 | 0.020 |
Why?
|
| Vitamin A | 1 | 2011 | 111 | 0.020 |
Why?
|
| Curriculum | 1 | 2014 | 575 | 0.020 |
Why?
|
| Aging | 1 | 1996 | 911 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2014 | 848 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2014 | 931 | 0.020 |
Why?
|
| Hypertension | 1 | 2019 | 1535 | 0.020 |
Why?
|
| Acetylcysteine | 1 | 2012 | 296 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2012 | 659 | 0.020 |
Why?
|
| Butadienes | 1 | 2009 | 26 | 0.020 |
Why?
|
| Anthracenes | 1 | 2009 | 26 | 0.020 |
Why?
|
| Endoglin | 1 | 2008 | 3 | 0.020 |
Why?
|
| Growth Hormone | 1 | 2008 | 51 | 0.020 |
Why?
|
| Nitriles | 1 | 2009 | 68 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2008 | 24 | 0.020 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2009 | 140 | 0.020 |
Why?
|
| Capillaries | 1 | 2009 | 105 | 0.020 |
Why?
|
| Pertussis Toxin | 1 | 2008 | 72 | 0.020 |
Why?
|
| Nerve Growth Factors | 1 | 2008 | 75 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2009 | 134 | 0.020 |
Why?
|
| Shellfish | 1 | 2008 | 8 | 0.020 |
Why?
|
| Glucagon | 1 | 2008 | 22 | 0.020 |
Why?
|
| Jurkat Cells | 1 | 2008 | 59 | 0.020 |
Why?
|
| Foodborne Diseases | 1 | 2008 | 14 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2009 | 175 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2008 | 150 | 0.020 |
Why?
|
| Wnt Proteins | 1 | 2008 | 57 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2008 | 230 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2008 | 147 | 0.020 |
Why?
|
| Multigene Family | 1 | 2008 | 93 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2008 | 188 | 0.020 |
Why?
|
| Eye Proteins | 1 | 2008 | 160 | 0.020 |
Why?
|
| Fatty Acids | 1 | 2008 | 222 | 0.020 |
Why?
|
| Pyridines | 1 | 2009 | 261 | 0.020 |
Why?
|
| Serpins | 1 | 2008 | 205 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2008 | 791 | 0.020 |
Why?
|
| Adolescent | 1 | 2019 | 8912 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2008 | 331 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2009 | 331 | 0.020 |
Why?
|
| Pregnancy Complications | 1 | 2008 | 286 | 0.020 |
Why?
|
| Insulin | 1 | 2008 | 619 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2008 | 617 | 0.010 |
Why?
|
| Aged | 1 | 2019 | 14862 | 0.010 |
Why?
|
| Fats, Unsaturated | 1 | 1995 | 1 | 0.010 |
Why?
|
| Animal Nutritional Physiological Phenomena | 1 | 1995 | 12 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 1995 | 1040 | 0.010 |
Why?
|